Menu
Back to Journals » International Journal of Women's Health » PCOS and Fertility Treatments
International Journal of Women's Health
ISSN: 1179-1411
- View all (1516)
- Volume 16, 2024 (68)
- Volume 15, 2023 (192)
- Volume 14, 2022 (164)
- Volume 13, 2021 (121)
- Volume 12, 2020 (134)
- Volume 11, 2019 (70)
- Volume 10, 2018 (87)
- Volume 9, 2017 (101)
- Volume 8, 2016 (75)
- Volume 7, 2015 (102)
- Volume 6, 2014 (111)
- Volume 5, 2013 (96)
- Volume 4, 2012 (73)
- Volume 3, 2011 (53)
- Volume 2, 2010 (48)
- Volume 1, 2009 (21)
Journal Articles:
- The Prevention, Early Diagnosis and Treatment of Cervical Cancer (5)
- Pain Relief and Care for Endometriosis (3)
- The Vulvodynia Frontier: Where do we go from here? (1)
- Prediction and prevention of preterm birth (1)
- Abortion: accessibility and safety (2)
- Window to the womb: amniotic fluid volume and postnatal outcomes (1)
PCOS and Fertility Treatments
Polycystic ovary syndrome (PCOS) affects 6–10% of women in reproductive age and is characterized by hyperandrogenism, insulin resistance, and chronic anovulation. It is a heterogeneous syndrome with not completely understood aetiology that is related to a complex interaction between metabolic, endocrine, genetic, and environmental factors.
This is an important topic as women diagnosed with PCOS are at higher risk for type 2 diabetes, high blood pressure, obesity, and endometrial cancer. Increasing evidence suggests that insulin resistance and secondary hyperinsulinemia play a key synergistic role with hyperandrogenism in the development and maintenance of metabolic alterations and anovulation or irregular cycles in both obese and lean patients with PCOS.